The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: A decision centered on empowering patients and their physicians Editorial
| Authors: | Subbiah, V.; Solit, D. B.; Chan, T. A.; Kurzrock, R. |
| Title: | The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: A decision centered on empowering patients and their physicians |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | 9 |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | 1115 |
| End Page: | 1118 |
| Language: | English |
| DOI: | 10.1016/j.annonc.2020.07.002 |
| PUBMED: | 32771306 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Editorial -- Export Date: 1 September 2020 -- Source: Scopus |
